Skip to main content

Day: December 11, 2024

Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling with U.S. Patient Cohort to be Added in 2025

Currently enrolling randomized, double-blind, placebo-controlled, dose-finding, Phase 2 clinical trial to evaluate the safety and efficacy of KDS2010 in patients with Alzheimer’s disease with mild cognitive impairment and mild dementia is currently recruiting in South Korea in 114 patients and U.S. cohort will be added in 2025. KDS2010 (Tisolagiline) is a new reversible selective monoamine oxidase B (MAO-B) inhibitor being studied for its potential in treating neurodegenerative diseases like Alzheimer’s disease. Apart from its role as a MAO-B inhibitor, it also influences astrocytic GABA inhibition. In neurodegenerative diseases like Alzheimer’s, altered GABAergic activity and dysfunction in astrocytic regulation of neurotransmitter systems contribute to cognitive decline and neuroinflammation. A highly selective and reversible...

Continue reading

Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement

DHA Omega-3 Supplements from CanolaHealth Canada has Approved Nutriterra DHA Canola as an ingredient in dietary supplementsWEST SACRAMENTO, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) — Nutriterra® Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims:Supports heart health and cardiovascular function Supports normal brain function Source of docosahexaenoic acid (DHA) for maintaining good health Source of alpha-linolenic acid (ALA) for maintaining good health Source of an essential fatty acid for the maintenance of good health Source...

Continue reading

Fnac Darty: Preliminary results: 96.70% of the share capital of Unieuro succesfully reached (including treasury shares)

PRESS RELEASEIvry-sur-Seine, France — December 11, 2024, 18h45 CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY WHERE SUCH COMMUNICATION WOULD VIOLATE THE RELEVANT APPLICABLE REGULATION VOLUNTARY PUBLIC TENDER AND EXCHANGE OFFER FOR ALL THE SHARES OF UNIEURO PRELIMINARY RESULTS OF THE PROCEDURE TO COMPLY WITH THE OBLIGATION TO PURCHASE UNDER ART. 108, PAR. 2, OF THE CFA 96.70% OF THE SHARE CAPITAL OF UNIEURO SUCCESFULLY REACHED (INCLUDING TREASURY SHARES)Preliminary results of the Procedure to Comply with the Obligation to Purchase under Art. 108, Par. 2, of the CFA: 3.04% of Unieuro’s share capital tendered, which cumulated with the 93.32% already owned by the Offerors...

Continue reading

Mercury Introduces Digital Signal Processing Products Powered by Altera’s Newest Agilex™ 9 FPGAs

Mercury’s DRF2270 system-on-module, featuring Altera’s latest Agilex 9 FPGA.Mercury’s DRF2270 system-on-module, featuring Altera’s latest Agilex 9 FPGA.ANDOVER, Mass., Dec. 11, 2024 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, today introduced a system-on-module (SOM) and 3U SOSA-aligned OpenVPX board powered by Altera’s™ most advanced Agilex 9 Direct RF FPGA chips. The DRF2270 SOM and DRF5270 3U board are the latest additions to Mercury’s portfolio of Direct RF digital signal processing products that use Altera FPGAs to detect and process information from a wide portion of the electromagnetic spectrum. These commercially available products directly digitize radio frequency signals at the antenna, eliminating...

Continue reading

Solvac: announcement of a second interim dividend to be paid on January 30, 2025

Press Release Regulated information Solvac announces a second interim dividend for the financial year 2024 to be paid on January 30, 2025 Solvac will announce on March 7, 2025, the interim dividend equivalent to the balance ex-2024 As announced on August 2, 2024, Solvac confirms its policy of distributing almost all the dividends received from Solvay and Syensqo after deducting its costs and financial expenses. As a reminder, Solvac paid on August 27, 2024 a first interim dividend for the 2024 financial year of €3.486 gross per share. The Board of Directors has decided today the payment of a second interim dividend ex-2024 of €1.48 gross per share. This payment will be made on Thursday January 30, 2025. The Board of Directors also decided that the interim dividend equivalent to the balance ex-2024 will be announced on March 7, 2025, along...

Continue reading

Quadient Launches SimplyMail in Europe to Help Small Businesses Leverage Digital Solutions to Enhance Efficiency in Mail Operations

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, today announced the launch in Europe of SimplyMail, a solution designed to address the growing needs for smaller businesses to automate and optimize their mail operations with ease. Small businesses often face the challenge of managing time-consuming tasks like mail and parcel handling while trying to stay agile and efficient, especially in remote work environments. SimplyMail, designed by Quadient’s research and development teams, offers a simple, user-friendly SaaS solution that enables small businesses to send physical mail—including registered letters—and parcels with just a few clicks, all from their existing digital environment. The solution enhances flexibility and efficiency without the need for complex IT systems...

Continue reading

Governance Evolution at BIC

                             GOVERNANCE EVOLUTION AT BIC BIC Announces Preparations for CEO Gonzalve BichDeparture by September 30th, 2025 Clichy, France – December 11, 2024 – Today, the BIC Board of Directors and Gonzalve Bich have announced that they will begin a transition process intended to close out Gonzalve’s tenure and appoint a new CEO by September 30th, 2025. Having acknowledged Gonzalve’s decision, the BIC Board of Directors collectively wishes to thank Gonzalve publicly for his achievements and contributions during his over two decades of service to BIC. Gonzalve will continue to perform his duties until his departure, ensuring a coordinated and gradual transition so that the Group can maintain momentum, a profitable growth trajectory and its commercial discipline. Accordingly, Gonzalve has agreed to carry on his duties...

Continue reading

MR. ÉRIC DONNET IS APPOINTED AT THE SUPERVISORY BOARD OF ARGAN

Press release – Neuilly-sur-Seine, Wednesday, December 11, 2024 – 5.45 pm Mr. Éric Donnet is appointed at the Supervisory Board of ARGAN Upon proposal of the Nominations and Remuneration Committee, ARGAN’s Supervisory Board, which met on December 10, 2024, has unanimously decided to appoint Mr. Éric DONNET as an independent member of the Supervisory Board, upon this day. Mr. Éric DONNET graduated from the ICN (Institut Commercial de Nancy) and holds a DESCF (French master’s degree in management control, accountancy and financial management), and has acquired over 25 years of experience in the financial and real estate fields. He was, more particularly, the CEO of Groupama Immobilier and Chairman of Groupama Gan REIM from 2014 to 2024. He is now the CEO of the Daniel Féau group, since March 2024. This appointment is provisional to replace...

Continue reading

BIC ACQUIRES TANGLE TEEZER, A PREMIUM DETANGLING HAIRCARE COMPANY

BIC ACQUIRES TANGLE TEEZER, A PREMIUM DETANGLING HAIRCARE COMPANY Acquisition of a market-leading, fast-growing and profitable brand Builds upon BIC’s capabilities to further accelerate innovation and synergies in an attractive high growth segment Clichy, France – December 11, 2024 – BIC announced today the acquisition of Tangle Teezer, a premium detangling haircare company. In a world where consumers are increasingly turning to brands that prioritize high quality and exceptional value, Tangle Teezer and BIC share a common DNA — delivering joy and simplicity in everyday life while championing innovative solutions and industrial excellence. BIC acquired 100% of Tangle Teezer for a total consideration of approximately €200 million1. Tangle Teezer is a pioneering, fast-growing and profitable haircare company headquartered in London, United...

Continue reading

Faropoint Expands Capabilities with New Industrial Development Project in Southern New Jersey

Tech-Enabled Firm to Develop 73,800 SF Class A Industrial Property in Strategic Location HOBOKEN, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Faropoint, a leading tech-enabled US industrial real estate investment manager, today announced the acquisition of 9.18 acres of land in Greenwich, New Jersey for a new development project. The off-market acquisition, located at Block 255, Lot 1.02 on Swedesboro Road, aligns with Faropoint’s strategy of identifying opportunities in key logistics markets. Faropoint plans to develop a 73,800 square foot Class A industrial property on the site, featuring state-of-the-art specifications including 1,600 amps of 480v power, 15 loading positions, 2 drive-in doors, ESFR sprinkler systems, and a 32′ clear height. Faropoint has secured final site plan approval for the project. Benjamin Wachs,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.